בלסטווין טבע

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

VINBLASTINE SULFATE

Commercializzato da:

ABIC MARKETING LTD, ISRAEL

Codice ATC:

L01CA01

Forma farmaceutica:

תמיסה להזרקה

Composizione:

VINBLASTINE SULFATE 1 MG / 1 ML

Via di somministrazione:

תוך-ורידי

Tipo di ricetta:

אין צורך במרשם

Prodotto da:

PHARMACHEMIE B.V., (TEVA GROUP) ,THE NETHERLANDS

Gruppo terapeutico:

VINBLASTINE

Area terapeutica:

VINBLASTINE

Indicazioni terapeutiche:

Vinblastine has proved effective in the treatment of the following neoplasms, either alone or in conjunction with other oncolytic drugs:Frequently Responsive Malignancies :• Generalized Hodgkin's disease (Stages III and IV, Ann Arbor modification of Rye staging system)• Non-Hodgkin's lymphoma: - Reticulum-cell sarcoma - Lymphosarcoma• Mycosis fungoides.• Neuroblastoma.• Histiocytosis X.Less Frequently Responsive Malignancies :• Choriocarcinoma resistant to other chemotherapeutic agents.• Embryonal carcinoma of the testis.• Carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.

Data dell'autorizzazione:

2016-08-31